The CANMAT and ISBD Guidelines for the Treatment of Bipolar Disorder: Summary and a 2023 Update of Evidence

Overview

Journal Focus (Am Psychiatr Publ)

Specialty Medical Education

Date 2024 May 2

PMID 38695002

Authors

Kamyar Keramatian

Nellai K Chithra

Lakshmi N Yatham

Affiliations

Soon will be listed here.

Abstract

Bipolar disorder is a complex and heterogeneous psychiatric condition that affects more than 2% of the population. The assessment and treatment of bipolar disorder can be a challenge for clinicians, given its clinical complexity and the rapidly changing treatment landscape with the growing range of treatment options that are becoming available for various phases of the illness. To help clinicians navigate the complexity involved in the assessment and management of bipolar disorder, the guidelines of the 2018 Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) synthesized the evidence on the efficacy, safety, and tolerability of treatments for bipolar disorder and translated it into first-, second-, and third-line treatment recommendations. The main objective of this contribution is to provide clinicians with a summary of the 2018 CANMAT/ISBD guideline recommendations with the addition of any new evidence for the treatment of bipolar disorder across the lifespan.

Citing Articles

Synaptic protein expression in bipolar disorder patient-derived neurons implicates PSD-95 as a marker of lithium response.

Rohr K, Mishra H, Amin J, Nakhla T, McCarthy M Neuropharmacology. 2025; 268:110313.

PMID: 39824303 PMC: 11830515. DOI: 10.1016/j.neuropharm.2025.110313.

References

Geller B, Cooper T, Sun K, Zimerman B, Frazier J, Williams M . Double-blind and placebo-controlled study of lithium for adolescent bipolar disorders with secondary substance dependency. J Am Acad Child Adolesc Psychiatry. 1998; 37(2):171-8. DOI: 10.1097/00004583-199802000-00009. View

Tsai S, Lee H, Chen C, Huang Y . Cognitive impairment in later life in patients with early-onset bipolar disorder. Bipolar Disord. 2007; 9(8):868-75. DOI: 10.1111/j.1399-5618.2007.00498.x. View

Hirschfeld R, Calabrese J, Weissman M, Reed M, Davies M, Frye M . Screening for bipolar disorder in the community. J Clin Psychiatry. 2003; 64(1):53-9. DOI: 10.4088/jcp.v64n0111. View

Jeste D, Alexopoulos G, Bartels S, Cummings J, Gallo J, Gottlieb G . Consensus statement on the upcoming crisis in geriatric mental health: research agenda for the next 2 decades. Arch Gen Psychiatry. 2003; 56(9):848-53. DOI: 10.1001/archpsyc.56.9.848. View

Cyprien F, Guillaume S, Jaussent I, Lopez-Castroman J, Mercier G, Olie E . Impact of axis-I comorbidity and suicidal behavior disorders on sensitivity and specificity of the Mood Disorder Questionnaire in complex depressed inpatients. Compr Psychiatry. 2014; 55(4):876-82. DOI: 10.1016/j.comppsych.2014.02.004. View

Friborg O, Martinsen E, Martinussen M, Kaiser S, Overgard K, Rosenvinge J . Comorbidity of personality disorders in mood disorders: a meta-analytic review of 122 studies from 1988 to 2010. J Affect Disord. 2013; 152-154:1-11. DOI: 10.1016/j.jad.2013.08.023. View

Keramatian K, Torres I, Yatham L . Neurocognitive functioning in bipolar disorder: What we know and what we don't. Dialogues Clin Neurosci. 2022; 23(1):29-38. PMC: 9286730. DOI: 10.1080/19585969.2022.2042164. View

Westman J, Hallgren J, Wahlbeck K, Erlinge D, Alfredsson L, Osby U . Cardiovascular mortality in bipolar disorder: a population-based cohort study in Sweden. BMJ Open. 2013; 3(4). PMC: 3641504. DOI: 10.1136/bmjopen-2012-002373. View

Yatham L, Vieta E, McIntyre R, Jain R, Patel M, Earley W . Broad Efficacy of Cariprazine on Depressive Symptoms in Bipolar Disorder and the Clinical Implications. Prim Care Companion CNS Disord. 2020; 22(5). DOI: 10.4088/PCC.20m02611. View

10.

Cassidy F, Ahearn E, Carroll B . A prospective study of inter-episode consistency of manic and mixed subtypes of bipolar disorder. J Affect Disord. 2002; 67(1-3):181-5. DOI: 10.1016/s0165-0327(01)00446-3. View

11.

Zimmerman M, Ruggero C, Chelminski I, Young D . Is bipolar disorder overdiagnosed?. J Clin Psychiatry. 2008; 69(6):935-40. DOI: 10.4088/jcp.v69n0608. View

12.

Tajika A, Hori H, Iga J, Koshikawa Y, Ogata H, Ogawa Y . Mood Stabilizers and Antipsychotics for Acute Mania: Systematic Review and Meta-Analysis of Augmentation Therapy vs Monotherapy From the Perspective of Time to the Onset of Treatment Effects. Int J Neuropsychopharmacol. 2022; 25(10):839-852. PMC: 9593220. DOI: 10.1093/ijnp/pyac050. View

13.

Smith L, Cornelius V, Azorin J, Perugi G, Vieta E, Young A . Valproate for the treatment of acute bipolar depression: systematic review and meta-analysis. J Affect Disord. 2009; 122(1-2):1-9. DOI: 10.1016/j.jad.2009.10.033. View

14.

Yatham L, Kennedy S, Parikh S, Schaffer A, Bond D, Frey B . Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018; 20(2):97-170. PMC: 5947163. DOI: 10.1111/bdi.12609. View

15.

Calabrese J, Durgam S, Satlin A, Vanover K, Davis R, Chen R . Efficacy and Safety of Lumateperone for Major Depressive Episodes Associated With Bipolar I or Bipolar II Disorder: A Phase 3 Randomized Placebo-Controlled Trial. Am J Psychiatry. 2021; 178(12):1098-1106. DOI: 10.1176/appi.ajp.2021.20091339. View

16.

Sonne S, Brady K, MORTON W . Substance abuse and bipolar affective disorder. J Nerv Ment Dis. 1994; 182(6):349-52. DOI: 10.1097/00005053-199406000-00007. View

17.

Suppes T, Durgam S, Kozauer S, Chen R, Lakkis H, Davis R . Adjunctive lumateperone (ITI-007) in the treatment of bipolar depression: Results from a randomized placebo-controlled clinical trial. Bipolar Disord. 2023; 25(6):478-488. DOI: 10.1111/bdi.13310. View

18.

Axelson D, Birmaher B, Findling R, Fristad M, Kowatch R, Youngstrom E . Concerns regarding the inclusion of temper dysregulation disorder with dysphoria in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. J Clin Psychiatry. 2011; 72(9):1257-62. PMC: 3581329. DOI: 10.4088/JCP.10com06220. View

19.

Schaffer A, Isometsa E, Tondo L, Moreno D, Turecki G, Reis C . International Society for Bipolar Disorders Task Force on Suicide: meta-analyses and meta-regression of correlates of suicide attempts and suicide deaths in bipolar disorder. Bipolar Disord. 2014; 17(1):1-16. PMC: 6296224. DOI: 10.1111/bdi.12271. View

20.

Kishi T, Sakuma K, Okuya M, Matsuda Y, Esumi S, Hashimoto Y . Effects of a conventional mood stabilizer alone or in combination with second-generation antipsychotics on recurrence rate and discontinuation rate in bipolar I disorder in the maintenance phase: A systematic review and meta-analysis of randomized,.... Bipolar Disord. 2021; 23(8):789-800. DOI: 10.1111/bdi.13053. View